HomeMembersCommittees ▶ Committee

Tobacco Action Committee

Chair Harold J. Farber, MD, MSPH Houston, TX
Vice Chair Enid R. Neptune, MD Baltimore, MD
Committee Member Ellen L. Burnham, MD Denver, CO
Committee Member Kai-Hakon Carlsen, MD, PhD Oslo, Norway
Committee Member Michelle Eakin, PhD Baltimore, MD
Committee Member Patricia A. Folan, RN, DNP Great Neck, NY
Committee Member Hasmeena Kathuria, MD Boston, MA
Committee Member Frank T. Leone, MD, MS Philadelphia, PA
Committee Member Farzad Moazed, MD San Francisco, CA
Committee Member Smita Pakhale, MD, FRCPC, MSCE Ottawa, ON, Canada
Committee Member David P. Sachs, MD Palo Alto, CA
Committee Member Fernando Urrego New Orleans, LA
Staff Courtney L. White New York, NY
Staff Gary Ewart Washington, DC

The Tobacco Action Committee is charged with organizing and coordinating the ATS tobacco control activities. These activities will include research, clinical, educational, advocacy and policy activities with the ultimate goal of minimizing the impact of tobacco on morbidity and mortality worldwide. The committee will strive to enhance the ability of the ATS to participate more fully in the investigation of the root causes of tobacco use; treatment of nicotine dependence; and advocacy efforts to eliminate its use. The Committee will communicate and collaborate with similar committees or bodies in other organizations such as the Forum of International Respiratory Societies and the European Respiratory Society Tobacco Action and Control Committee.

Benchmarks, 2017-2018:
• Complete the approved ATS position statement on tobacco harm reduction;

• Collaborate with ATS Government Relations and others with interest in tobacco control to develop evidence based tobacco control policy recommendations;

• Collaborate with other relevant ATS committees (such as education, health policy, and international lung health) and assemblies to develop program proposals for the ATS international conference that address tobacco dependence, tobacco policy, and/or health impacts of tobacco and nicotine;

• Collaborate with other relevant ATS committees (such as education, health policy, and international lung health) to develop statement proposal(s) relating to tobacco control and/or tobacco dependence issues for the scientific community, policy makers, and the lay public;

• Establish a mechanism to inform ATS electronic media audience about important and timely tobacco control action items;

• Engage AAP and ACOG to explore areas of overlapping tobacco control advocacy potential;

• Engage junior members in ATS Tobacco Control Activities.